[Combination of phenylpyrrolidinopentane (Katovit) and oxazepam (Adumbran). A double-blind comparison with opipramol (Insidon) in depressive syndromes].
D000328:Adult; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009888:Opipramol / Q000009:adverse effects / Q000627:therapeutic use*; D010076:Oxazepam / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011759:Pyrrolidines / Q000008:administration & dosage / Q000627:therapeutic use*; D011760:Pyrrolidinones / Q000009:adverse effects
D011759:Pyrrolidines; D011760:Pyrrolidinones; D010076:Oxazepam; D009888:Opipramol; C005598:prolintane
Kombination von Phenylpyrrolidinopentan (Katovit) mit Oxazepam (Adumbran). Ein Wirkungsvergleich im Doppelblindversuch mit Opipramol (Insidon) bei depressiven Syndromen.